drugset / Trial / NCT06481488
A Study of E2086 in Healthy Adult Participants
RandomizedParallel-groupQuadruple-blindBasic science
Summary
The primary purpose of the study is to evaluate the safety and tolerability following multiple ascending doses of E2086 in healthy adult participants.
Timeline
- Start
- 2024-06-25
- Primary completion
- 2024-12-13
- Completion
- 2024-12-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | E2086 | Unknown | — | Oral |
Indications
No indication recorded.